Nanobiotix (NBTX) Receivables - Other: 2019-2024

  • Nanobiotix's Receivables - Other rose 108.30% to $3.2 million in Q4 2024 from the same period last year, while for Dec 2024 it was $3.2 million, marking a year-over-year increase of 108.30%. This contributed to the annual value of $3.2 million for FY2024, which is 107.19% up from last year.
  • Nanobiotix's Receivables - Other amounted to $3.2 million in Q4 2024, which was up 108.30% from $1.5 million recorded in Q4 2023.
  • Nanobiotix's Receivables - Other's 5-year high stood at $3.9 million during Q4 2021, with a 5-year trough of $1.1 million in Q4 2020.
  • For the 2-year period, Nanobiotix's Receivables - Other averaged around $2.4 million, with its median value being $2.4 million (2024).
  • As far as peak fluctuations go, Nanobiotix's Receivables - Other declined by 20.40% in 2020, and later spiked by 252.29% in 2021.
  • Over the past 4 years, Nanobiotix's Receivables - Other (Quarterly) stood at $1.1 million in 2020, then soared by 252.29% to $3.9 million in 2021, then reached $1.5 million in 2023, then skyrocketed by 108.30% to $3.2 million in 2024.
  • Its Receivables - Other was $3.2 million in Q4 2024, compared to $1.5 million in Q4 2023 and $3.9 million in Q4 2021.